Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Patients Hospitalized for Pre-eclampsia
- Sponsor
- Central Hospital, Nancy, France
- Enrollment
- 155
- Locations
- 1
- Primary Endpoint
- Performing a self-measurement of blood pressure
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
Pre-eclampsia is a disease characterized by placental damage leading to a cascade of complications during pregnancy. It is initially manifested by high blood pressure and the presence of albumin in the urine. It can lead to emergency hospitalization in severe cases and cause major complications or even death in the mother and the fetus.
Several studies observing the outcome of patients with pre-eclampsia have shown an increased long-term cardiovascular risk in these patients, justifying regular medical follow-up with the treating physician and specialists, mainly cardiologists.
The main objective of this research is to describe the cardiovascular risk assessment actions implemented by the treating general practitioner in the year following pre-eclampsia (blood pressure measurement in the office, self-measurement of blood pressure, ABPM, cardiological consultation, biological monitoring of blood (creatininemia, LDL, fasting glycemia) or urine (albuminurie/creatininurie ratio), and screening and management of possible smoking).
Investigators
Jean-Marc BOIVIN
Principal investigator
Central Hospital, Nancy, France
Eligibility Criteria
Inclusion Criteria
- •Patients ≥ 18 years hospitalized for preeclampsia at the Nancy regional maternity hospital
Exclusion Criteria
- •Fetal death in utero;
- •Adult Person subject to a legal protection measure (guardianship, curatorship, safeguard of justice);
- •Person deprived of liberty by a judicial or administrative decision;
- •Person subject to psychiatric care under constraint by virtue of articles L. 3212-1 and L. 3213-1 of the Public Health Code.
Outcomes
Primary Outcomes
Performing a self-measurement of blood pressure
Time Frame: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as self-measurement of blood pressure. Composite outcome with 2, 3, 4, 5 and 6
Performing a cardiological consultation
Time Frame: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as cardiological consultation. Composite outcome with 2, 3, 4, 5 and 6
Performing a biological monitoring of blood (creatinine, LDL cholesterol, fasting glucose, albuminuria creatinuria ratio)
Time Frame: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as biological monitoring of blood (creatinine, LDL, fasting glucose) or urine (Albuminuria/creatininuria ratio). Composite outcome with 2, 3, 4, 5 and 6.
Performing a blood pressure measurement by the general practitioner
Time Frame: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as blood pressure measurement in the office. Composite outcome with 2, 3, 4, 5 and 6
Performing a ambulatory measurement of blood pressure
Time Frame: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as ambulatory measurement of blood pressure. Composite outcome with 2, 3, 4, 5 and 6
Screening and management of possible smoking
Time Frame: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as screening and management of possible smoking. Composite outcome with 1, 2, 3, 4 and 5
Secondary Outcomes
- Pre eclampsia information mode(Up to 5 years following pre eclampsia)
- Performing a blood pressure measurement(Up to one year following pre eclampsia)
- Performing a biological monitoring of blood (creatinine, LDL cholesterol, fasting glucose, albuminuria creatinuria ratio)(Up to one year following pre eclampsia)
- Screening and management of possible smoking(Up to one year following pre eclampsia)
- Cardiovascular risk assessment by the patient(Up to 5 years following pre eclampsia)
- Knowledge of pre-eclampsia status(Up to 5 years following pre eclampsia)
- Performing a self-measurement of blood pressure(Up to one year following pre eclampsia)
- Rate of stroke following pre-eclampsia(Up to 5 years following pre eclampsia)
- Rate of coronary accident following pre-eclampsia(Up to 5 years following pre eclampsia)
- Cardiovascular risk assessment by the general practitioner(Up to 5 years following pre eclampsia)
- Rate of hypertension following pre-eclampsia(Up to 5 years following pre eclampsia)
- Performing a cardiological consultation(Up to one year following pre eclampsia)
- Performing a ambulatory measurement of blood pressure(Up to one year following pre eclampsia)